Jc. Tardiff et al., A TRUNCATED CARDIAC TROPONIN-T MOLECULE IN TRANSGENIC MICE SUGGESTS MULTIPLE CELLULAR MECHANISMS FOR FAMILIAL HYPERTROPHIC CARDIOMYOPATHY, The Journal of clinical investigation, 101(12), 1998, pp. 2800-2811
Mutations in multiple cardiac sarcomeric proteins including myosin hea
vy chain (MyHC) and cardiac troponin T (cTnT) cause a dominant genetic
heart disease, familial hypertrophic cardiomyopathy (FHC). Patients w
ith mutations in these two genes have quite distinct clinical characte
ristics. Those with MyHC mutations demonstrate more significant and un
iform cardiac hypertrophy and a variable frequency of sudden death. Pa
tients with cTnT mutations generally exhibit mild or no hypertrophy, b
ut a high frequency of sudden death at an early age. To understand the
basis for these distinctions and to study the pathogenesis of the dis
ease, we have created transgenic mice expressing a truncated mouse cTn
T allele analogous to one found in FHC patients. Mice expressing trunc
ated cTnT at low (< 5%) levels develop cardiomyopathy and their hearts
are significantly smaller (18-27%) than wild type. These animals also
exhibit significant diastolic dysfunction and milder systolic dysfunc
tion, Animals that express higher levels of transgene protein die with
in 24 h of birth. Transgenic mouse hearts demonstrate myocellular disa
rray and have a reduced number of cardiac myocytes that are smaller in
size. These studies suggest that multiple cellular mechanisms result
in the human disease, which is generally characterized by mild hypertr
ophy, but, also, frequent sudden death.